454 related articles for article (PubMed ID: 26560027)
21. Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population.
He J; Wang F; Zhu J; Zhang R; Yang T; Zou Y; Xia H
J Cell Mol Med; 2016 Aug; 20(8):1481-90. PubMed ID: 27019310
[TBL] [Abstract][Full Text] [Related]
22. Common genetic variants in NEFL influence gene expression and neuroblastoma risk.
Capasso M; Diskin S; Cimmino F; Acierno G; Totaro F; Petrosino G; Pezone L; Diamond M; McDaniel L; Hakonarson H; Iolascon A; Devoto M; Maris JM
Cancer Res; 2014 Dec; 74(23):6913-24. PubMed ID: 25312269
[TBL] [Abstract][Full Text] [Related]
23. LIM domain only 1: an oncogenic transcription cofactor contributing to the tumorigenesis of multiple cancer types.
Zhao GF; Du LQ; Zhang L; Jia YC
Chin Med J (Engl); 2021 Apr; 134(9):1017-1030. PubMed ID: 33870932
[TBL] [Abstract][Full Text] [Related]
24. A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a.
Ye J; Tucker NR; Weng LC; Clauss S; Lubitz SA; Ellinor PT
Am J Hum Genet; 2016 Dec; 99(6):1281-1291. PubMed ID: 27866707
[TBL] [Abstract][Full Text] [Related]
25. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ
J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701
[TBL] [Abstract][Full Text] [Related]
26. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.
Cimmino F; Avitabile M; Diskin SJ; Vaksman Z; Pignataro P; Formicola D; Cardinale A; Testori A; Koster J; de Torres C; Devoto M; Maris JM; Iolascon A; Capasso M
Int J Cancer; 2018 Dec; 143(11):2828-2837. PubMed ID: 30132831
[TBL] [Abstract][Full Text] [Related]
27. Functional Analysis of a Novel Genome-Wide Association Study Signal in SMAD3 That Confers Protection From Coronary Artery Disease.
Turner AW; Martinuk A; Silva A; Lau P; Nikpay M; Eriksson P; Folkersen L; Perisic L; Hedin U; Soubeyrand S; McPherson R
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):972-83. PubMed ID: 26966274
[TBL] [Abstract][Full Text] [Related]
28. Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci.
Niittymäki I; Tuupanen S; Li Y; Järvinen H; Mecklin JP; Tomlinson IP; Houlston RS; Karhu A; Aaltonen LA
BMC Med Genet; 2011 Feb; 12():23. PubMed ID: 21314996
[TBL] [Abstract][Full Text] [Related]
29. Integrative Genomic Analysis Predicts Causative
Zhang Y; Manjunath M; Zhang S; Chasman D; Roy S; Song JS
Cancer Res; 2018 Apr; 78(7):1579-1591. PubMed ID: 29351903
[TBL] [Abstract][Full Text] [Related]
30. Genetic Predisposition to Neuroblastoma Results from a Regulatory Polymorphism that Promotes the Adrenergic Cell State.
Weichert-Leahey N; Shi H; Tao T; Oldridge DA; Durbin AD; Abraham BJ; Zimmerman MW; Zhu S; Wood AC; Reyon D; Joung JK; Young RA; Diskin SJ; Maris JM; Look AT
bioRxiv; 2023 Mar; ():. PubMed ID: 36909587
[TBL] [Abstract][Full Text] [Related]
31. Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans.
Latorre V; Diskin SJ; Diamond MA; Zhang H; Hakonarson H; Maris JM; Devoto M
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):658-63. PubMed ID: 22328350
[TBL] [Abstract][Full Text] [Related]
32. A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression.
Kycia I; Wolford BN; Huyghe JR; Fuchsberger C; Vadlamudi S; Kursawe R; Welch RP; Albanus RD; Uyar A; Khetan S; Lawlor N; Bolisetty M; Mathur A; Kuusisto J; Laakso M; Ucar D; Mohlke KL; Boehnke M; Collins FS; Parker SCJ; Stitzel ML
Am J Hum Genet; 2018 Apr; 102(4):620-635. PubMed ID: 29625024
[TBL] [Abstract][Full Text] [Related]
33. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.
Nguyen le B; Diskin SJ; Capasso M; Wang K; Diamond MA; Glessner J; Kim C; Attiyeh EF; Mosse YP; Cole K; Iolascon A; Devoto M; Hakonarson H; Li HK; Maris JM
PLoS Genet; 2011 Mar; 7(3):e1002026. PubMed ID: 21436895
[TBL] [Abstract][Full Text] [Related]
34.
Zhang J; Lin H; Wang J; He J; Zhang D; Qin P; Yang L; Yan L
Oncotarget; 2017 Sep; 8(39):65620-65626. PubMed ID: 29029458
[TBL] [Abstract][Full Text] [Related]
35. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
36. LMO1 is a novel oncogene in lung cancer, and its overexpression is a new predictive marker for anti-EGFR therapy.
Zhang Y; Yang J; Wang J; Guo H; Jing N
Med Oncol; 2014 Aug; 31(8):99. PubMed ID: 25037573
[TBL] [Abstract][Full Text] [Related]
37. Allelic Imbalance in Regulation of ANRIL through Chromatin Interaction at 9p21 Endometriosis Risk Locus.
Nakaoka H; Gurumurthy A; Hayano T; Ahmadloo S; Omer WH; Yoshihara K; Yamamoto A; Kurose K; Enomoto T; Akira S; Hosomichi K; Inoue I
PLoS Genet; 2016 Apr; 12(4):e1005893. PubMed ID: 27055116
[TBL] [Abstract][Full Text] [Related]
38. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
Zuber V; Bettella F; Witoelar A; ; ; ; ; Andreassen OA; Mills IG; Urbanucci A
BMC Genomics; 2017 Mar; 18(1):270. PubMed ID: 28359301
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
Hungate EA; Applebaum MA; Skol AD; Vaksman Z; Diamond M; McDaniel L; Volchenboum SL; Stranger BE; Maris JM; Diskin SJ; Onel K; Cohn SL
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117357
[TBL] [Abstract][Full Text] [Related]
40. The osteoporosis risk variant rs9820407 at 3p22.1 acts as an allele-specific enhancer to regulate CTNNB1 expression by long-range chromatin loop formation.
Wang Y; Lu L; Niu Y; Zhang Q; Cheng C; Huang H; Huang X; Huang Q
Bone; 2021 Dec; 153():116165. PubMed ID: 34461284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
